Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: A promising system for glioblastoma treatment

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages

  Costa, Pedro M ^a,b   Cardoso, Ana L ^a   Mendonça, Liliana S ^a   Serani, Angelo ^a   Custódia, Carlos ^b   Conceição, Mariana ^a,c   Simões, Sérgio ^a,c   Moreira, João N ^a,c   De Almeida, Luís Pereira ^a,c   De Lima, Maria C Pedroso ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

chlorotoxin; glioblastoma; liposome; miR 21; stable nucleic acid lipid particle

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHLOROTOXIN; LIPOSOME; NANOCARRIER; PEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; EVALUATION; FLOW CYTOMETRY; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNALIZATION; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; NUCLEIC ACID TRANSPORT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 84879940866     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.30     Document Type: Article

References (49)

1. Ohgaki, H and Kleihues, P (2007). Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-1453. (Pubitemid 47339290)
2. Khasraw, M and Lassman, AB (2010). Advances in the treatment of malignant gliomas. Curr Oncol Rep 12: 26-33.
3. Stupp, R, Hegi, ME, Mason, WP, van den Bent, MJ, Taphoorn, MJ, Janzer, RC et al.; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 10: 459-466.
4. Novakova, J, Slaby, O, Vyzula, R and Michalek, J (2009). MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386: 1-5.
5. Volinia, S, Calin, GA, Liu, CG, Ambs, S, Cimmino, A, Petrocca, F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
6. Costa, PM, Cardoso, AL, Nóbrega, C, Pereira de Almeida, LF, Bruce, JN, Canoll, P et al. (2013). MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum Mol Genet 22: 904-918.
7. Dong, CG, Wu, WK, Feng, SY, Wang, XJ, Shao, JF and Qiao, J (2012). Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol 41: 1005-1012.
8. Qian, X, Ren, Y, Shi, Z, Long, L, Pu, P, Sheng, J et al. (2012). Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Mol Pharm 9: 2636-2645.
9. Catuogno, S, Esposito, CL, Quintavalle, C, Condorelli, G, de Franciscis, V and Cerchia, L (2012). Nucleic acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 2012: 735135.
10. Cardoso, AL, Simões, S, de Almeida, LP, Plesnila, N, Pedroso de Lima, MC, Wagner, E et al. (2008). Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. J Control Release 132: 113-123.
11. Hutterer, M, Gunsilius, E and Stockhammer, G (2006). Molecular therapies for malignant glioma. Wien Med Wochenschr 156: 351-363. (Pubitemid 44174329)
12. Kanai, R, Rabkin, SD, Yip, S, Sgubin, D, Zaupa, CM, Hirose, Y et al. (2012). Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. J Natl Cancer Inst 104: 42-55.
13. Gomes-da-Silva, LC, Santos, AO, Bimbo, LM, Moura, V, Ramalho, JS, Pedroso de Lima, MC et al. (2012). Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment. Int J Pharm 434: 9-19.
14. Judge, AD, Robbins, M, Tavakoli, I, Levi, J, Hu, L, Fronda, A et al. (2009). Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice. J Clin Invest 119: 661-673.
15. Mendonça, LS, Firmino, F, Moreira, JN, Pedroso de Lima, MC and Simões, S (2010). Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Bioconjug Chem 21: 157-168.
16. Mamelak, AN and Jacoby, DB (2007). Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4: 175-186. (Pubitemid 46389915)
17. Veiseh, O, Kievit, FM, Fang, C, Mu, N, Jana, S, Leung, MC et al. (2010). Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Biomaterials 31: 8032-8042.
18. Veiseh, O, Sun, C, Fang, C, Bhattarai, N, Gunn, J, Kievit, F et al. (2009). Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the bloodbrain barrier. Cancer Res 69: 6200-6207.
19. Deshane, J, Garner, CC and Sontheimer, H (2003). Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278: 4135-4144. (Pubitemid 36801150)
20. Lu, Z, Liu, M, Stribinskis, V, Klinge, CM, Ramos, KS, Colburn, NH et al. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27: 4373-4379. (Pubitemid 352010003)
21. Meng, F, Henson, R, Wehbe-Janek, H, Ghoshal, K, Jacob, ST and Patel, T (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
22. Aguilar-Morante, D, Morales-Garcia, JA, Sanz-SanCristobal, M, Garcia-Cabezas, MA, Santos, A and Perez-Castillo, A (2010). Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8. PLoS ONE 5: e13879.
23. Pedroso de Lima, MC, Simoes, S, Pires, P, Faneca, H and Duzgunes, N (2001). Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv Drug Deliv Rev 47: 277-294. (Pubitemid 32324118)
24. Semple, SC, Klimuk, SK, Harasym, TO, Dos Santos, N, Ansell, SM, Wong, KF et al. (2001). Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim Biophys Acta 1510: 152-166. (Pubitemid 32149893)
25. Zimmermann, TS, Lee, AC, Akinc, A, Bramlage, B, Bumcrot, D, Fedoruk, MN et al. (2006). RNAi-mediated gene silencing in non-human primates. Nature 441: 111-114.
26. Morrissey, DV, Lockridge, JA, Shaw, L, Blanchard, K, Jensen, K, Breen, W et al. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23: 1002-1007. (Pubitemid 41114035)
27. Li, SD and Huang, L (2008). Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5: 496-504.
28. Remaut, K, Lucas, B, Braeckmans, K, Demeester, J and De Smedt, SC (2007). Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J Control Release 117: 256-266. (Pubitemid 46161877)
29. Santos, AO, da Silva, LC, Bimbo, LM, de Lima, MC, Simões, S and Moreira, JN (2010). Design of peptide-targeted liposomes containing nucleic acids. Biochim Biophys Acta 1798: 433-441.
30. Asangani, IA, Rasheed, SA, Nikolova, DA, Leupold, JH, Colburn, NH, Post, S et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
31. Gaur, AB, Holbeck, SL, Colburn, NH and Israel, MA (2011). Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro-oncology 13: 580-590.
32. Göke, R, Barth, P, Schmidt, A, Samans, B and Lankat-Buttgereit, B (2004). Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol, Cell Physiol 287: C1541-C1546. (Pubitemid 39507671)
33. Lino, MM and Merlo, A (2011). PI3Kinase signaling in glioblastoma. J Neurooncol 103: 417-427.
34. Yang, HS, Jansen, AP, Nair, R, Shibahara, K, Verma, AK, Cmarik, JL et al. (2001). A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 20: 669-676. (Pubitemid 32179335)
35. Ren, Y, Kang, CS, Yuan, XB, Zhou, X, Xu, P, Han, L et al. (2010). Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed 21: 303-314.
36. Ren, Y, Zhou, X, Mei, M, Yuan, XB, Han, L, Wang, GX et al. (2010). MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 10: 27.
37. Neyns, B, Sadones, J, Chaskis, C, Dujardin, M, Everaert, H, Lv, S et al. (2011). Phase II study of sunitinib malate in patients with recurrent high-grade glioma. J Neurooncol 103: 491-501.
38. Moreira, JN, Gaspar, R and Allen, TM (2001). Targeting Stealth liposomes in a murine model of human small cell lung cancer. Biochim Biophys Acta 1515: 167-176. (Pubitemid 33086833)
39. Bartlett, DW, Su, H, Hildebrandt, IJ, Weber, WA and Davis, ME (2007). Impact of tumorspecific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 104: 15549-15554. (Pubitemid 47502954)
40. Kumar, P, Wu, H, McBride, JL, Jung, KE, Kim, MH, Davidson, BL et al. (2007). Transvascular delivery of small interfering RNA to the central nervous system. Nature 448: 39-43. (Pubitemid 47037001)
41. de Wolf, HK, Snel, CJ, Verbaan, FJ, Schiffelers, RM, Hennink, WE and Storm, G (2007). Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm 331: 167-175. (Pubitemid 46216670)
42. Trabulo, S, Cardoso, AM, Santos-Ferreira, T, Cardoso, AL, Simões, S and Pedroso de Lima, MC (2011). Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents. Mol Pharm 8: 1120-1131.
43. Lyons, SA, O'Neal, J and Sontheimer, H (2002). Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39: 162-173. (Pubitemid 34817056)
44. Banker, G and Goslin, K (1998). Culturing Nerve Cells (2nd Edition). The MIT: Cambridge, MA, USA.
45. Xiong, Q, Wilson, WK and Pang, J (2007). The Liebermann-Burchard reaction: sulfonation, desaturation, and rearrangment of cholesterol in acid. Lipids 42: 87-96. (Pubitemid 46490747)
46. Moreira, JN, Ishida, T, Gaspar, R and Allen, TM (2002). Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity. Pharm Res 19: 265-269. (Pubitemid 34211842)
47. Pfaffl, MW (2001). A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 29: e45.
48. Schneider, CA, Rasband, WS and Eliceiri, KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
49. Costa, PM, Cardoso, AL, Pereira de Almeida, LF, Bruce, JN, Canoll, P and Pedroso de Lima, MC (2012). PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. Hum Mol Genet 21: 5118-5130.